IGEA S.p.A. Revenue and Competitors
Estimated Revenue & Valuation
- IGEA S.p.A.'s estimated annual revenue is currently $66.5M per year.
- IGEA S.p.A.'s estimated revenue per employee is $251,000
Employee Data
- IGEA S.p.A. has 265 Employees.
- IGEA S.p.A. grew their employee count by 23% last year.
IGEA S.p.A. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is IGEA S.p.A.?
IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients' quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA develops biophysical treatments in two main areas: - Orthopedics: to improve bone healing and joint preservation. - Oncology: to treat cancer. IGEA is the world leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.
keywords:N/A
N/A
Total Funding
265
Number of Employees
$66.5M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IGEA S.p.A. News
Aetna, Inc. Bioventus LLC DJO Global, Inc. elizur Corporation IGEA S.p.A.. Medtronic plc. Orchid Medical, Inc. Orthofix International N.V.
IGEA S.p.A.. Medtronic plc. Orchid Medical, Inc. Orthofix International N.V.. Ossatec Benelux B.V.. Smith & Nephew plc